tirzepatide & semaglutide Shows Superior Weight Loss Over in Phase 3 Trial Hair loss with GLP-1 drugs

Patients need to understand that the safety and efficacy of tirzepatide use without diabetes might not have the same level of evidence as it does for those with diabetes, and such usage is at the physicians discretion following a rigorous assessment process

Your wellness journey is unique, and your supplement routine should reflect that

But human observational evidence is increasingly reassuring on major malformations when confounding is handled carefullyfor example, large datasets show no substantial increased risk of major congenital malformations with early exposure, and a European teratology cohort reported no increase in major birth defects vs diabetes/high-BMI comparators

The Doctors at BMI Doctors recommend that you weigh the potential benefits against the potential risks before taking this medication while breastfeeding